User profiles for Klaus Schmierer

Klaus Schmierer

The Blizard Institute, Queen Mary University of London, Medicine & Dentistry//Barts Health …
Verified email at qmul.ac.uk
Cited by 11168

Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

K Schmierer, F Scaravilli, DR Altmann… - Annals of …, 2004 - Wiley Online Library
Several quantitative magnetic resonance (MR) measures are used to investigate multiple
sclerosis (MS) in vivo. Precise quantitative investigation of the histopathological correlates of …

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

…, E Havrdova, V Limmroth, CH Polman, K Schmierer… - The Lancet, 2008 - thelancet.com
Background Oral fumarate (BG00012) might have dual anti-inflammatory and neuroprotective
effects. Our aim was to assess the efficacy and safety of BG00012 in patients with relapsing…

Association between pathological and MRI findings in multiple sclerosis

…, P Preziosa, À Rovira, K Schmierer… - The Lancet …, 2019 - thelancet.com
Pathological evaluation is the gold standard for identifying processes related to multiple
sclerosis that explain disease manifestations, and for guiding the development of new treatments…

[HTML][HTML] Diffusion tensor imaging of post mortem multiple sclerosis brain

K Schmierer, CAM Wheeler-Kingshott, PA Boulby… - Neuroimage, 2007 - Elsevier
Magnetic resonance imaging (MRI) is being used to probe the central nervous system (CNS)
of patients with multiple sclerosis (MS), a chronic demyelinating disease. Conventional T 2 -…

No cerebrocervical venous congestion in patients with multiple sclerosis

F Doepp, F Paul, JM Valdueza, K Schmierer… - Annals of …, 2010 - Wiley Online Library
Objective: Multiple sclerosis (MS) is characterized by demyelination centered around
cerebral veins. Recent studies suggested this topographic pattern may be caused by venous …

[HTML][HTML] Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

…, B Turner, S Gnanapavan, C Offiah, K Schmierer… - Multiple sclerosis and …, 2015 - Elsevier
The management of multiple sclerosis is becoming increasingly complex with the emergence
of new and more effective disease-modifying therapies (DMT). We propose a new …

Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation

K Schmierer, CAM Wheeler‐Kingshott… - … in Medicine: An …, 2008 - Wiley Online Library
Unfixed and fixed postmortem multiple sclerosis (MS) brain is being used to probe pathology
underlying quantitative MR (qMR) changes. Effects of fixation on qMR indices in MS brain …

COVID‐19 vaccine response in people with multiple sclerosis

…, SJ Moat, NP Robertson, K Schmierer… - Annals of …, 2022 - Wiley Online Library
Objective The purpose of this study was to investigate the effect of disease modifying
therapies on immune response to severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2…

Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain

K Schmierer, DJ Tozer, F Scaravilli… - Journal of Magnetic …, 2007 - Wiley Online Library
Purpose To investigate the relationship of myelin content, axonal density, and gliosis with
the fraction of macromolecular protons (f B ) and T 2 relaxation of the macromolecular pool (T …

COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases

…, M Marta, S Reyes, K Schmierer… - Clinical & …, 2020 - academic.oup.com
Although most autoimmune diseases are considered to be CD4 T cell- or antibody-mediated,
many respond to CD20-depleting antibodies that have limited influence on CD4 and …